Fact Sheet for Healthcare Providers: ZEUS ELISA SARS-CoV-2 IgG Test System | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: ZEUS ELISA SARS-CoV-2 IgG Test System

10/06/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 10/6/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ZEUS ELISA SARS-CoV-2 IgG Test System. The ZEUS ELISA SARS-CoV-2 IgG Test System is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma (dipotassium EDTA, lithium heparin and sodium citrate). (PDF)